Transcranial Electrical Stimulation for Cervical Dystonia
- Conditions
- Primary Cervical Dystonia
- Interventions
- Device: transcranial electrical stimulation
- Registration Number
- NCT03369613
- Lead Sponsor
- University of Colorado, Denver
- Brief Summary
There are two phases.
Phase I: A single visit which includes a screening, clinical scales, and a MRI scan with simultaneous tES/sham tES in a randomized block design. Enrolls both Cervical Dystonia (CD) patients and healthy controls.
Phase II: 5 consecutive days of 30-90 min visits to campus for tES or sham tES. Transcranial magnetic stimulation (TMS) measures and clinical scales will also be included on Day 1 and Day 5 visits. Enrolls only CD patients.
- Detailed Description
Phase I:
Enrolls both CD patients and healthy controls.
One approximately 3 hour visit which includes:
* a screening \& neurological exam,
* clinical scales \& questionnaires,
* a (approx.) 60 min MRI scan with simultaneous tES/sham tES in a randomized block design and EMG
Phase II:
Enrolls only CD patients.
Five consecutive days of study visits.
Day 1:
* TMS screening,
* repeated neurological assessment and clinical scales if \>1 month since MRI visit
* 30 min TMS session with concurrent EMG
* 20 min tES or sham tES session
Days 2-4:
- 20 min tES or sham tES session
Day 5:
* 20 min tES or sham tES session
* 30 min TMS session with concurrent EMG
* repeated neurological assessment and clinical scales
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
- Right-handed
- On a stable dose of all medications used to treat dystonia for the month previous to enrollment
- No botox injections in the 10 weeks previous to enrollment
- Any contraindication to MRI scanning, tES, or TMS (e.g pregnancy, history of seizures, significant systemic medical conditions, untreated psychiatric or neurological conditions)
- Evidence on neurological exam of any potentially confounding neurological disorder
- Evidence of significant cognitive impairment
- Patients with dystonia symptoms beginning prior to the age of 18 will be excluded
- Patients with secondary dystonia resulting from medications or that are part of another neurological disorder (e.g. Parkinson's disease) will be excluded
- Medication that might predispose the subject to seizures
Healthy Controls
Inclusion Criteria:
- Right-handed
Exclusion Criteria:
- Any contraindication to MRI scanning, tES, or TMS (e.g pregnancy, history of seizures, significant systemic medical conditions, untreated psychiatric or neurological conditions)
- Evidence on neurological exam of any potentially confounding neurological disorder
- Evidence of significant cognitive impairment
- Medication that might predispose the subject to seizures
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description MRI - HC tACS transcranial electrical stimulation Healthy controls in Phase 1- transcranial electrical stimulation set to alternating current MRI - CD tCDS transcranial electrical stimulation Cervical dystonia in Phase 1 transcranial electrical stimulation set to direct current MRI - HC tDCS transcranial electrical stimulation Healthy controls in Phase 1 transcranial electrical stimulation set to direct current Phase II - Stim transcranial electrical stimulation Cervical dystonia in Phase 2 transcranial electrical stimulation setting is active MRI - CD tACS transcranial electrical stimulation Cervical dystonia in Phase 1 transcranial electrical stimulation set to alternating current Phase II - Sham transcranial electrical stimulation Cervical dystonia in Phase 2 transcranial electrical stimulation setting is sham
- Primary Outcome Measures
Name Time Method Phase II: Improvement in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) score Day 1, Day 5 A change in TWSTRS scores following five daily sessions of inhibitory tACS.
Phase I: A change in brain functional connectivity in primary cervical dystonia Day 1 A change in mean functional connectivity between the pallidum and putamen during a resting state in CD patients during inhibitory tACS targeting the sensorimotor network.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Colorado Denver
🇺🇸Aurora, Colorado, United States